Primary Open-angle Glaucoma: Clinical Trials

5 trials for Primary Open-angle Glaucoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated, 1 unknown. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 3, Terminated 1, Unknown 1

Follow Primary Open-angle Glaucoma: new trials by email Literature Review of Primary Open-angle Glaucoma trials Research Report on Primary Open-angle Glaucoma

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension
BREMEN eye drops, Combigan® - Ocular Hypertension, Primary Open-angle Glaucoma
Phase 3CompletedEMS4062021-02-012024-02-20
Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension
Levobetaxolol eye drops, Betaxolol eye drops - Primary Open-angle Glaucoma, Ocular Hypertension
Phase 3CompletedZhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.3662019-01-042023-05-12
A Clinical Study to Evaluate the Efficacy and Safety of CKD-351
CKD-351, Latanoprost, D930 - Primary Open-angle Glaucoma, Ocular Hypertension
Phase 3UnknownChong Kun Dang Pharmaceutical3842018-12-072018-12-03
PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM)
PRO-122, Timolol eye drops, Dorzolamide-Timolol Ophthalmic - Primary Open-angle Glaucoma
Phase 3TerminatedLaboratorios Sophia S.A de C.V.512017-11-062025-03-06
A Multi-center, Randomized, Blinded Evaluator, Active Control, Parallel, Phase III Study to Evaluate the Efficacy and Safety of TJO-002 in POAG or Ocular Hypertension Patients
TJO-002, Latanoprost - Primary Open-angle Glaucoma, Ocular Hypertension
Phase 3CompletedTaejoon Pharmaceutical Co., Ltd.1462016-04-262019-09-04

Narrower conditions

Glaucoma, Open-Angle (5)  ·  Ocular Hypertension (4)  ·  Glaucoma (1)

Broader conditions

Eye Diseases (5)  ·  Glaucoma (4)  ·  Ocular Hypertension (1)

Interventions

Latanoprost (2)  ·  Brimonidine Tartrate (1)  ·  Brimonidine Tartrate, Timolol Maleate Drug Combination (1)  ·  Timolol (1)  ·  dorzolamide (1)

Sponsors

Chong Kun Dang Pharmaceutical (1)  ·  EMS (1)  ·  Laboratorios Sophia S.A de C.V. (1)  ·  Taejoon Pharmaceutical Co., Ltd. (1)  ·  Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. (1)

Countries

South Korea (2)  ·  Brazil (1)  ·  China (1)  ·  Colombia (1)  ·  Mexico (1)

Top investigators

Jian Ge, MD (1)  ·  KiHo Park (1)  ·  Leopoldo Baiza, MD (1)

Results publications

PMID 41737851